These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Increasing in vitro resistance to fluconazole in Cryptococcus neoformans Cambodian isolates: April 2000 to March 2002. Sar B; Monchy D; Vann M; Keo C; Sarthou JL; Buisson Y J Antimicrob Chemother; 2004 Aug; 54(2):563-5. PubMed ID: 15254027 [TBL] [Abstract][Full Text] [Related]
4. Cryptococcal meningitis in AIDS. Iyer RS; Banker DD Indian J Med Sci; 2002 Dec; 56(12):593-7. PubMed ID: 14514241 [TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology and antifungal susceptibility of Cryptococcus neoformans isolates from Ugandan AIDS patients. Pfaller M; Zhang J; Messer S; Tumberland M; Mbidde E; Jessup C; Ghannoum M Diagn Microbiol Infect Dis; 1998 Nov; 32(3):191-9. PubMed ID: 9884835 [TBL] [Abstract][Full Text] [Related]
6. Cryptococcus neoformans isolates from Yaoundé human immunodeficiency virus-infected patients exhibited intra-individual genetic diversity and variation in antifungal susceptibility profiles between isolates from the same patient. Kammalac Ngouana T; Drakulovski P; Krasteva D; Kouanfack C; Reynes J; Delaporte E; Boyom FF; Mallié M; Bertout S J Med Microbiol; 2016 Jul; 65(7):579-589. PubMed ID: 27100672 [TBL] [Abstract][Full Text] [Related]
7. Burden of cryptococcal meningitis in Malawi. Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421 [TBL] [Abstract][Full Text] [Related]
8. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis. Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679 [TBL] [Abstract][Full Text] [Related]
9. Cryptococcal meningitis due to Cryptococcus neoformans genotype AFLP1/VNI in Iran: a review of the literature. Badali H; Alian S; Fakhim H; Falahatinejad M; Moradi A; Mohammad Davoudi M; Hagen F; Meis JF Mycoses; 2015 Dec; 58(12):689-93. PubMed ID: 26444438 [TBL] [Abstract][Full Text] [Related]
10. In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia. Trpković A; Pekmezović M; Barać A; Crnčević Radović L; Arsić Arsenijević V J Mycol Med; 2012 Sep; 22(3):243-8. PubMed ID: 23518082 [TBL] [Abstract][Full Text] [Related]
11. Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole. Agudelo CA; Muñoz C; Ramírez A; Tobón AM; de Bedout Bact C; Cano LE; Restrepo A Rev Iberoam Micol; 2015; 32(4):214-20. PubMed ID: 25637338 [TBL] [Abstract][Full Text] [Related]
12. Cryptococcus neoformans and C. gattii isolates from both HIV-infected and uninfected patients: antifungal susceptibility and outcome of cryptococcal disease. Nascimento E; Vitali LH; Kress MRVZ; Martinez R Rev Inst Med Trop Sao Paulo; 2017; 59():e49. PubMed ID: 28793019 [TBL] [Abstract][Full Text] [Related]
13. Clinical and laboratory features of cryptococcal meningitis in HIV-AIDS patients. Deo S J Assoc Physicians India; 1995 Oct; 43(10):724. PubMed ID: 8773019 [No Abstract] [Full Text] [Related]
14. Sporadic occurrence of cryptococcal meningitis in HIV-seronegative patients: Uncommon etiology? Das S; Datt S; Roy P; Saha R; Xess I Indian J Pathol Microbiol; 2017; 60(2):236-238. PubMed ID: 28631642 [TBL] [Abstract][Full Text] [Related]
15. Cryptococcosis among HIV negative liver disease patients: Epidemiology, underlying conditions, antifungal susceptibility profile from tertiary care hepatobiliary center. Patel D; Khillan V; Patel N; Kale P Indian J Med Microbiol; 2023; 46():100465. PubMed ID: 37690316 [TBL] [Abstract][Full Text] [Related]
16. Cryptococcal meningitis in Lilongwe and Blantyre, Malawi. Maher D; Mwandumba H J Infect; 1994 Jan; 28(1):59-64. PubMed ID: 8163834 [TBL] [Abstract][Full Text] [Related]
17. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina. Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081 [TBL] [Abstract][Full Text] [Related]
18. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species. Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368 [TBL] [Abstract][Full Text] [Related]
19. Combination antifungal therapies for HIV-associated cryptococcal meningitis: a randomised trial. Brouwer AE; Rajanuwong A; Chierakul W; Griffin GE; Larsen RA; White NJ; Harrison TS Lancet; 2004 May; 363(9423):1764-7. PubMed ID: 15172774 [TBL] [Abstract][Full Text] [Related]
20. Epidemiology of cryptococcal meningitis and fluconazole heteroresistance in Huang Y; Zhang Y; Yang S; Lu H; Yu H; Wang X; Jia X; Tang D; Wu L; Huang S; Yang P Microbiol Spectr; 2024 Aug; 12(8):e0072524. PubMed ID: 39007718 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]